{"id":974759,"date":"2026-06-23T09:47:48","date_gmt":"2026-06-23T13:47:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/"},"modified":"2026-06-23T09:47:48","modified_gmt":"2026-06-23T13:47:48","slug":"nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/","title":{"rendered":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>News Summary:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Industry and research leaders including Dassault Syst\u00e8mes, Databricks, Lilly, OpenAI, Schr\u00f6dinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists.<\/li>\n<li>NVIDIA BioNeMo Agent Toolkit \u2014 including NVIDIA Nemotron, NemoClaw, OpenShell and BioNeMo \u2014 gives agents accelerated life sciences tools spanning biology, chemistry, genomics and drug discovery.<\/li>\n<li>New NVIDIA BioNeMo tools give agents the context and know-how to execute scientific computing \u2014 improving accuracy, task completion and token efficiency.<\/li>\n<\/ul>\n<p>SAN DIEGO, June  23, 2026  (GLOBE NEWSWIRE) &#8212; <strong>BIO <\/strong>&#8212; NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life sciences era.<\/p>\n<p>Including more than a decade\u2019s worth of NVIDIA life sciences libraries, tools and open models, the toolkit enables AI agents, scientists and labs to work together by gathering evidence, reasoning across findings, running computational experiments and recommending the next best steps to accelerate discovery.<\/p>\n<p>It gives any agent or AI platform \u2014 from general-purpose assistants to specialized scientific agents, software platforms and in-house biopharma systems \u2014 the tools needed to synthesize and summarize scientific knowledge, call models, evaluate results, reason and execute next actions.<\/p>\n<p>The toolkit includes NVIDIA BioNeMo\u2122 and is powered by NVIDIA NIM\u2122 microservices, NVIDIA Parabricks<sup>\u00ae<\/sup>, NVIDIA NeMo\u2122 and NVIDIA Nemotron\u2122 technologies, along with accelerated computing and skills \u2014 providing an open and trusted foundation for agentic life sciences.<\/p>\n<p>More than 50 leading companies are already using it to advance scientific discovery, tapping into agent-callable skills for tasks including protein structure prediction, molecular docking, generative chemistry, genomic analysis, protein design and biomarker discovery.<\/p>\n<p>\u201cFrontier models are the brains. BioNeMo is the scientific toolbox. Together, they give AI agents the skills of a PhD research assistant and the speed of a supercomputer,\u201d said Jensen Huang, founder and CEO of NVIDIA. \u201cFor the first time, researchers can build AI agents that understand scientific knowledge, use scientific tools and execute scientific workflows. This is a new way to do science \u2014 one that can dramatically accelerate discovery across biology, chemistry, genomics and medicine.\u201d<\/p>\n<p>Open model and research organizations \u2014 including the Arc Institute, Open Molecular Software Foundation and the University of Washington\u2019s Institute for Protein Design (IPD) \u2014 are working with NVIDIA to use BioNeMo to advance frontier models and make them more accessible through agent-ready workflows. The IPD collaboration has accelerated runtimes for state-of-the-art biodesign models like RosettaFold3, resulting in 2x faster performance than the prior-generation model, and many additional applications to accelerate protein design efforts are ongoing, giving researchers tools at a scale and cost not before possible.<\/p>\n<p>\u201cEvery tool we\u2019ve built for protein design is only as powerful as the scientists who can efficiently access it,\u201d said David Baker, professor of biochemistry at the University of Washington School of Medicine and director of the Institute for Protein Design. \u201cThe next leap in science won\u2019t come from a single discovery; it will come from the speed of iterative designs and agents that can repeatedly reason through the complexity of biology at a speed humans never could.\u201d<\/p>\n<p>\n        <strong>Agent-Ready Tools and Skills for Life Sciences<\/strong><br \/>\n        <br \/>Life sciences is one of the world\u2019s most important scientific frontiers, with global scientific R&amp;D reaching $3.8 trillion and annual pharmaceutical budgets approaching $300 billion.<\/p>\n<p>Agentic workflows can help the industry iterate faster while reducing costs and maximizing the probability of success. With the toolkit allowing developers to transform general-purpose agents into life sciences agents in minutes, researchers can run experiments faster, continuously learn from results and close the loop between hypothesis and discovery, with some companies extending this iteration into physical labs.<\/p>\n<p>A general-purpose agent can struggle to navigate scientific workflows efficiently, needing to infer the correct tools, inputs, outputs and biological meaning along the way. With BioNeMo Agent Toolkit, agents can call the right tools, interpret results more accurately and gain scientific insights faster and more reliably.<\/p>\n<p>NVIDIA is optimizing the entire BioNeMo platform by turning libraries, models and frameworks into agent-callable tools.<\/p>\n<p>This includes harnessing <a href=\"https:\/\/blogs.nvidia.com\/blog\/nvidia-agent-toolkit-open-models-tools-skills-secure-runtime-ai-agents\" rel=\"nofollow\" target=\"_blank\"><u>NVIDIA Agent Toolkit<\/u><\/a> technologies such as NVIDIA Nemotron open models for the reasoning foundation, the NVIDIA NeMo RL library for reinforcement learning and NVIDIA NemoClaw\u2122 blueprints for secure, private agents that can reason across tasks, call tools and interact with data continuously.<\/p>\n<p>NVIDIA NIM microservices help agents call models and perform tasks. The NVIDIA OpenShell\u2122 runtime provides a controlled executable environment.<\/p>\n<p>The toolkit\u2019s components enable agents to complete workflows such as:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Virtual Screening: <\/strong>Agents can help researchers identify small-molecule drug candidates by generating and screening compounds, docking them to a target, predicting binding strength and filtering for drug-like properties. Then, the agent can output which candidates should be prioritized, compressing screening timelines from days to minutes.<\/li>\n<li>\n          <strong>Genomic Analysis and Target Discovery:<\/strong> Agents can help researchers transform raw sequencing data into prioritized genetic insights and biological targets. NVIDIA Parabricks accelerates alignment and variant calling, while genomic foundation models score variant effects and the agent ranks the most disease-relevant candidates for further study.<\/li>\n<li>\n          <strong>Protein Binder Design: <\/strong>Agents can help researchers design and validate candidates computationally before work begins, compressing traditionally labor-intensive design work.<\/li>\n<li>\n          <strong>Deep Biomedical Research: <\/strong>Agents connect real-world data to reasoning models to improve the efficiency and accuracy of various scientific and clinical development processes, including literature review, protocol generation, clinical trial screening and pharmacovigilance with the NVIDIA Biomedical AI-Q Research Agent.<\/li>\n<li>\n          <strong>Medical Imaging Analysis<\/strong>: Agents can help researchers process, segment, synthesize and reason over medical imaging data to support biomarker discovery, accelerating evidence generation across research workflows.<\/li>\n<\/ul>\n<p>\n        <strong>Life Sciences Ecosystem Builds With NVIDIA BioNeMo<\/strong><br \/>\n        <br \/>Companies across the technology and life sciences ecosystem are using the toolkit to advance agentic workflows.<\/p>\n<p>Frontier labs and scientific agent builders including Anthropic, Edison Scientific, Lila Sciences, OpenAI and Owkin are integrating with BioNeMo to help agents move from answering questions to completing scientific work. NVIDIA accelerated models and analysis libraries help shorten the time from hypothesis to insight.<\/p>\n<p>Scientific data and workflow platforms from Benchling, Certara, Databricks, Snowflake and Seqera are using BioNeMo Agent Toolkit to connect data systems with AI-powered science. BioNeMo skills can help agents query biological and chemical datasets, prepare model-ready inputs, launch reproducible workflows, analyze outputs and return insights directly within the platforms scientists and data teams already use daily.<\/p>\n<p>Diagnostics and pharmaceutical companies including Lilly and Natera are using BioNeMo Agent Toolkit to scale repeatable agentic workflows across discovery, translational research and clinical insight.<\/p>\n<p>AI-native biology companies including Boltz, Basecamp Research, Chai Discovery, Dyno, <a href=\"https:\/\/www.perturb.ai\/news-0623-tools\" rel=\"nofollow\" target=\"_blank\"><u>PerturbAI<\/u><\/a> and Proxima have collaborated with NVIDIA to develop tools to accelerate model-powered therapeutic design workflows.<\/p>\n<p>Computer-aided drug discovery software providers including Dassault Syst\u00e8mes, Cadence (OpenEye) and Schr\u00f6dinger are integrating the toolkit\u2019s capabilities into scientific applications used across discovery teams. Then, agents can help orchestrate molecular generation, docking and prediction, turning computer-aided design platforms into systems where researchers can ask questions, launch analyses and identify next-best actions faster.<\/p>\n<p>Lab instruments and automation companies including Automata, HighRes, Tecan, Thermo Fisher and autonomous data generation platform Medra are connecting systems with computational discovery powered by BioNeMo skills.<\/p>\n<p>AI clouds and AI infrastructure companies including Baseten, Modal and Nebius are using the toolkit to help developers build life sciences workflows as reliable hosted services. By supporting BioNeMo skills and tools through scalable application programming interfaces, managed compute and production inference environments, these companies can help move agentic biology workflows from prototypes into accessible services for researchers and enterprises.<\/p>\n<p>\n        <strong>Availability<\/strong><br \/>\n        <br \/>BioNeMo Agent Toolkit and skills are available now through the NVIDIA developer resources page and <a href=\"https:\/\/github.com\/NVIDIA-BioNeMo\/bionemo-agent-toolkit\" rel=\"nofollow\" target=\"_blank\"><u>GitHub<\/u><\/a>.<\/p>\n<p>\n        <strong>About NVIDIA<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.nvidia.com\/en-us\/\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>NVIDIA<\/u><br \/>\n        <\/a> is the world leader in AI and accelerated computing.<\/p>\n<p>\n        <strong>For further information, contact:<\/strong><br \/>\n        <br \/>Janette Ciborowski<br \/>Corporate Communications<br \/>NVIDIA Corporation<br \/><a href=\"mailto:press@nvidia.com\" rel=\"nofollow\" target=\"_blank\"><u>press@nvidia.com<\/u><\/a><\/p>\n<p>Certain statements in this press release including, but not limited to, statements as to: for the first time, researchers being able to build AI agents that understand scientific knowledge, use scientific tools and execute scientific workflows; expectations with respect to growth, performance, availability, and benefits of NVIDIA\u2019s products, services and technologies, and related trends and drivers; expectations with respect to NVIDIA\u2019s third party arrangements, including with its collaborators and partners; expectations with respect to technology developments, and related trends and drivers; projected market growth and trends; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the \u201csafe harbor\u201d created by those sections based on management\u2019s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA\u2019s reliance on third parties to manufacture, assemble, package and test NVIDIA\u2019s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA\u2019s existing products and technologies; market acceptance of NVIDIA\u2019s products or NVIDIA\u2019s partners\u2019 products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA\u2019s products or technologies when integrated into systems; NVIDIA\u2019s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company\u2019s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.<\/p>\n<p>\u00a9 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, BioNeMo, NemoClaw, Nemotron, NVIDIA NeMo, NVIDIA NIM, NVIDIA OpenShell and Parabricks are trademarks and\/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability and specifications are subject to change without notice.<\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/5ca024bb-1493-4542-96e6-7e98ec3c271c\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/5ca024bb-1493-4542-96e6-7e98ec3c271c<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjlkYjBjZmYtYzhmYS00ZDEwLTkzZDgtODI4MjM4YTk2ZDExLTEwMTg0ODUtMjAyNi0wNi0yMy1lbg==\/tiny\/NVIDIA-CORPORATION.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>News Summary: Industry and research leaders including Dassault Syst\u00e8mes, Databricks, Lilly, OpenAI, Schr\u00f6dinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists. NVIDIA BioNeMo Agent Toolkit \u2014 including NVIDIA Nemotron, NemoClaw, OpenShell and BioNeMo \u2014 gives agents accelerated life sciences tools spanning biology, chemistry, genomics and drug discovery. New NVIDIA BioNeMo tools give agents the context and know-how to execute scientific computing \u2014 improving accuracy, task completion and token efficiency. SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) &#8212; BIO &#8212; NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-974759","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"News Summary: Industry and research leaders including Dassault Syst\u00e8mes, Databricks, Lilly, OpenAI, Schr\u00f6dinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists. NVIDIA BioNeMo Agent Toolkit \u2014 including NVIDIA Nemotron, NemoClaw, OpenShell and BioNeMo \u2014 gives agents accelerated life sciences tools spanning biology, chemistry, genomics and drug discovery. New NVIDIA BioNeMo tools give agents the context and know-how to execute scientific computing \u2014 improving accuracy, task completion and token efficiency. SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) &#8212; BIO &#8212; NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic &hellip; Continue reading &quot;NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-23T13:47:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery\",\"datePublished\":\"2026-06-23T13:47:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/\"},\"wordCount\":1763,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/\",\"name\":\"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\",\"datePublished\":\"2026-06-23T13:47:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/","og_locale":"en_US","og_type":"article","og_title":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk","og_description":"News Summary: Industry and research leaders including Dassault Syst\u00e8mes, Databricks, Lilly, OpenAI, Schr\u00f6dinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists. NVIDIA BioNeMo Agent Toolkit \u2014 including NVIDIA Nemotron, NemoClaw, OpenShell and BioNeMo \u2014 gives agents accelerated life sciences tools spanning biology, chemistry, genomics and drug discovery. New NVIDIA BioNeMo tools give agents the context and know-how to execute scientific computing \u2014 improving accuracy, task completion and token efficiency. SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) &#8212; BIO &#8212; NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic &hellip; Continue reading \"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-23T13:47:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery","datePublished":"2026-06-23T13:47:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/"},"wordCount":1763,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/","name":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=","datePublished":"2026-06-23T13:47:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MDk1NyM3NjczNDYxIzIwMDY5MTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nvidia-announces-bionemo-agent-toolkit-tools-for-agents-to-accelerate-scientific-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA Announces BioNeMo Agent Toolkit \u2014 Tools for Agents to Accelerate Scientific Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/974759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=974759"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/974759\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=974759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=974759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=974759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}